Introducing ARIA: AI for Regulatory Intelligence & Authoring, our new AI agent, built on everything you already know from NuMantra.
May 26, 2025
admin
Incorporating patient-reported outcomes (PROs) and real-world evidence (RWE) into regulatory submissions is increasingly critical for demonstrating a therapy’s real-life benefit. Yet manual assembly of PRO data and RWE can be onerous and error-prone. By leveraging intelligent document processing and AI-driven RWE platforms, regulatory teams can automate the extraction, formatting, and integration of patient-centric data into eCTD dossiers—saving up to 70% of manual effort and improving data accuracy by 85%. This post explores global guidance on PROs and RWE, illustrates automation use cases, and provides a checklist to streamline your patient-centric eCTD workflow.
Patient-reported outcomes (PROs) capture a patient’s perspective on symptoms, function, and quality of life—data that regulators like FDA and EMA increasingly value alongside clinical trial metrics to assess a therapy’s benefit–risk profile (Ennov Software for Life). Meanwhile, real-world evidence (RWE)—drawn from electronic health records, registries, and wearables—provides insights into a drug’s performance in routine clinical practice (Applied Clinical Trials).
Challenge: Clinical sites collect PROs via paper or disparate ePRO systems—manual transcription is slow and error-prone.
Solution: AI-powered OCR and NLP capture PRO data directly from source systems (e.g., mobile apps, wearables) and populate eCTD-ready tables. Early adopters report 65% reduction in data cleaning time and 90% fewer transcription errors (PMC).
Challenge: RWE comes from multiple sources—registries, EHRs, claims—each with different formats.
Solution: Intelligent data pipelines automatically ingest, harmonize, and summarize RWE metrics (e.g., real-world safety incidence rates), generating Module 5 narrative sections with minimal human intervention. Companies using AI-driven RWE platforms have cut report generation time by 70% (Applied Clinical Trials).
Challenge: Ensuring PRO and RWE sections comply with eCTD formatting and metadata requirements.
Solution: Automated validation checks enforce bookmarks, metadata tags (e.g., data source, instrument name), and module placement. One RWE-focused sponsor eliminated 100% of formatting errors after adopting AI-enabled publishing software (IQVIA).
A mid-sized oncology sponsor used an AI-driven RWE platform to support a label expansion in Europe. The system ingested registry data on patient-reported fatigue and real-world progression-free survival rates. The RWE summary section was auto-generated in under 48 hours—compared to two weeks manually—with no formatting defects. The submission received rapid EMA acceptance with only minor clarifications, and time-to-approval improved by 30% .
Integrating patient-centric data—PROs and RWE—into eCTD submissions no longer needs to be a manual ordeal. By adopting AI for regulatory compliance, you can automate data extraction, harmonize diverse datasets, and generate eCTD-ready sections with unparalleled speed and accuracy. Doing so not only accelerates approval timelines but also enriches your submission with meaningful patient insights.
Ready to bring patient voices into your eCTD workflow?
Request a demo of our AI-powered PRO & RWE integration suite and see how quickly you can transform patient-centric data into regulatory impact.
From expert guidance to actionable regulatory insights, find the support that fits your needs.
Talk to a regulatory expert, or get one IND and eCTD insight each week.
By continuing, you agree to our Privacy Policy.
One short regulatory insight every week. No spam, unsubscribe anytime.
By continuing, you agree to our Privacy Policy.
72h
Share your email and our team will reply within one business day.
By continuing, you agree to our Privacy Policy.
Check stability, impurities, batch records and eCTD links in 5 minutes.
By continuing, you agree to our Privacy Policy